Alcohol and Neurovascular Control in Humans

Information

  • Research Project
  • 10237243
  • ApplicationId
    10237243
  • Core Project Number
    R01AA024892
  • Full Project Number
    5R01AA024892-06
  • Serial Number
    024892
  • FOA Number
    PA-13-302
  • Sub Project Id
  • Project Start Date
    9/15/2017 - 7 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    OROSZ, ANDRAS
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
  • Award Notice Date
    8/25/2021 - 3 years ago

Alcohol and Neurovascular Control in Humans

Project Summary There is wide-spread recognition that `binge' alcohol consumption is associated with increased cardiovascular risk, but much of this is based on epidemiological studies and mechanisms remain poorly understood. Sympathetic overactivity has been suggested as a potential mechanism for alcohol-mediated cardiovascular disease, but direct evidence is lacking. The proposed project represents our first step in the pursuit of a long- term goal to explore alcohol-mediated hypertension, stroke, and sudden cardiac death, and practical interventions that might reduce the incidence of these cardiovascular conditions. The proposed project focuses on the impact of evening alcohol consumption on nocturnal and early morning autonomic function and reactivity in male and female binge drinkers. In aim 1, will determine the effect of evening alcohol consumption on nocturnal autonomic control and sympathetic neural responsiveness the subsequent morning. Aim 2 will determine the influence of sex (male vs. female) and the ovarian cycle (early follicular vs. midluteal phase) on sympathetic neural responsiveness to evening alcohol in humans. Aim 3 will determine if continuous positive airway pressure (CPAP) blunts alcohol-mediated sympathoexcitation at night and early morning. An exploratory aim will determine if autonomic responses to alcohol and CPAP are associated with affective states and psychomotor performance. Our central hypothesis is that evening alcohol consumption will elicit sympathetic overactivity at night and the subsequent morning, and that this sympathoexcitation will be augmented women and blunted after CPAP treatment. The novelty and innovation of this project is that our mechanistic aims are bolstered with an interventional aim that includes a randomized, control trial (CPAP vs. sham-CPAP). The project utilizes established, gold-standard methods for assessing sleep (polysomnography) and sympathetic neural activity and reactivity (microneurography). In summary, this project will determine the impact of simulated `binge' alcohol consumption on neural cardiovascular function at times of elevated cardiovascular risk (i.e., sleep and early morning) in male and female binge drinkers, and test a potential therapeutic strategy (i.e., CPAP) to blunt alcohol-induced autonomic dysfunction.

IC Name
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
  • Activity
    R01
  • Administering IC
    AA
  • Application Type
    5
  • Direct Cost Amount
    258226
  • Indirect Cost Amount
    86400
  • Total Cost
    344626
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    273
  • Ed Inst. Type
    SCHOOLS OF EDUCATION
  • Funding ICs
    NIAAA:344626\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    AA
  • Study Section Name
    National Institute on Alcohol Abuse and Alcoholism Initial Review Group
  • Organization Name
    MONTANA STATE UNIVERSITY - BOZEMAN
  • Organization Department
    MISCELLANEOUS
  • Organization DUNS
    625447982
  • Organization City
    BOZEMAN
  • Organization State
    MT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    597170000
  • Organization District
    UNITED STATES